1. Evaluation of disinfectant efficacy when applied to the floor of poultry grow-out facilities;Payne;J. Appl. Poult. Res.,2005
2. NebuPure, NebuPure LLC, Charleston, SC.
3. Mycoplasmas in the etiology of multifactorial respiratory disease;Kleven;Poult. Sci.,1998
4. Poulvac Myco F, Zoetis United States, Parsippany, New Jersey.
5. Mycoplasma gallisepticum culture preparation. The MG vaccine was originally resuspended in 20 mL of sterile PBS. Seeding solutions were prepared by diluting the vaccine suspension in sterile PBS to 10E-6 (trial I) or 10E-5 (trials II & III).